Assessing Gadolinium-Based Contrast Agents in MRI in the Wake of Safety Concerns CME

The goal of this activity is to provide a balanced overview of the clinical significance of reports of gadolinium remaining in the brains of patients who receive multiple magnetic resonance imaging (MRI) scans using gadolinium-based contrast agents (GBCAs).